WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Corp. (NASDAQ:PSDV; ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced Dr. Paul Ashton, president and CEO of pSivida Corp., will present at the International Symposium on Ocular Pharmacology and Therapeutics Clinical meeting in Berlin, Germany July 9-12, 2015. This meeting will focus on the significant revolution that has and continues to take place with new drugs and modes of delivery to treat eye disease. Dr. Ashton’s presentation is part of the “Innovation in Ophthalmology” section to be held on Saturday, July 11.
Help employers find you! Check out all the jobs and post your resume.
